Total Payments
$841.42
2024 Payments
$115.51
Companies
11
Transactions
12
Medicare Patients
645
Medicare Billing
$85,214
Payment Breakdown by Category
Food & Beverage$841.42 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $841.42 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HemoSonics LLC | $185.74 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $131.93 | 2 | $0 (2023) |
| Relypsa, Inc. | $121.87 | 1 | $0 (2017) |
| Allergan Inc. | $107.81 | 1 | $0 (2017) |
| Inspire Medical Systems, Inc. | $96.64 | 1 | $0 (2024) |
| Werfen USA LLC | $87.23 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $42.97 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $18.87 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $17.10 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $15.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.51 | 2 | Inspire Medical Systems, Inc. ($96.64) |
| 2023 | $219.16 | 3 | AstraZeneca Pharmaceuticals LP ($131.93) |
| 2022 | $244.70 | 3 | HemoSonics LLC ($185.74) |
| 2021 | $17.10 | 1 | Janssen Pharmaceuticals, Inc ($17.10) |
| 2017 | $244.95 | 3 | Relypsa, Inc. ($121.87) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $96.64 | General |
| Category: NEUROLOGY | ||||||
| 10/11/2023 | Werfen USA LLC | — | Food and Beverage | Cash or cash equivalent | $87.23 | General |
| 08/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/15/2022 | HemoSonics LLC | QUNATRA QPLUS SYSTEM (Device), QUANTRA QPLUS SYSTEM | Food and Beverage | In-kind items and services | $185.74 | General |
| Category: HEMATOLOGY | ||||||
| 09/15/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $42.97 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Cardiovascular | ||||||
| 06/30/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/19/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $107.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/18/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Immunology | ||||||
| 04/19/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 166 | 314 | $70,746 | $22,729 |
| 2022 | 4 | 96 | 223 | $43,438 | $13,293 |
| 2021 | 6 | 164 | 318 | $69,175 | $21,102 |
| 2020 | 7 | 219 | 413 | $91,735 | $28,091 |
Total Patients
645
Total Services
1,268
Medicare Billing
$85,214
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 159 | $28,406 | $9,591 | 33.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 48 | $12,305 | $4,374 | 35.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 35 | $11,813 | $3,284 | 27.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 44 | 45 | $8,049 | $2,779 | 34.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $7,497 | $1,992 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $2,676 | $708.79 | 26.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 137 | $24,386 | $7,454 | 30.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 48 | $12,288 | $3,754 | 30.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 25 | 26 | $4,628 | $1,427 | 30.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 11 | 12 | $2,136 | $657.60 | 30.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 48 | 173 | $30,892 | $9,622 | 31.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 55 | $14,100 | $4,398 | 31.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 47 | 47 | $8,417 | $2,625 | 31.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $8,488 | $2,276 | 26.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $4,726 | $1,471 | 31.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $2,552 | $708.76 | 27.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 195 | $35,100 | $10,869 | 31.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 35 | 83 | $21,331 | $6,742 | 31.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 30 | 31 | $15,500 | $4,584 | 29.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 61 | 65 | $11,765 | $3,720 | 31.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 14 | 14 | $3,500 | $1,035 | 29.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 11 | 11 | $1,991 | $634.07 | 31.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 14 | $2,548 | $507.56 | 19.9% |
About Dr. S Didia, M.D
Dr. S Didia, M.D is a Internal Medicine healthcare provider based in El )Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356385355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. S Didia, M.D has received a total of $841.42 in payments from pharmaceutical and medical device companies, with $115.51 received in 2024. These payments were reported across 12 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($841.42).
As a Medicare-enrolled provider, Didia has provided services to 645 Medicare beneficiaries, totaling 1,268 services with total Medicare billing of $85,214. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location El )Paso, TX
- Active Since 06/16/2006
- Last Updated 02/18/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1356385355
Products in Payments
- QUNATRA QPLUS SYSTEM (Device) $185.74
- FARXIGA (Drug) $122.51
- Veltassa (Drug) $121.87
- AVYCAZ (Drug) $107.81
- INSPIRE (Device) $96.64
- INJECTAFER (Drug) $42.97
- ENTRESTO (Drug) $18.87
- XARELTO (Drug) $17.10
- ELIQUIS (Drug) $15.99
- SOLIRIS (Drug) $15.27
- BRILINTA (Drug) $9.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.